Market Cap 20.41M
Revenue (ttm) 0.00
Net Income (ttm) -39.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 161,700
Avg Vol 617,300
Day's Range N/A - N/A
Shares Out 17.01M
Stochastic %K 54%
Beta 1.35
Analysts Sell
Price Target $6.00

Company Profile

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 967 6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
TwongStocks
TwongStocks Sep. 12 at 8:27 PM
$CTXR files an amended 13D updating their ownership position in $CTOR. Ownership stake drops from 84.3% to 79.1% as a result of CTOR's offering. https://www.sec.gov/Archives/edgar/data/1506251/000121390025087227/xslSCHEDULE_13D_X01/primary_doc.xml CTXR still owns 66,049,615 shares (unchanged) CTOR now has 83,513,442 outstanding shares. CTXR owns 79.1%
0 · Reply
Applebat
Applebat Sep. 12 at 6:47 PM
$CTXR Lymphir gonna launch ANY DAY NOW! 🙄
0 · Reply
Idkwhattonamemyself
Idkwhattonamemyself Sep. 12 at 5:49 PM
$CTXR a securities fraud lawsuit likely won’t be possible because the lawsuit won’t make the lawyers any money.
1 · Reply
BALUGA825
BALUGA825 Sep. 11 at 2:49 PM
$CTOR $CTXR Lez Go ! Market is good today and probably tomorrow too. Slingshot for next week....
0 · Reply
TwongStocks
TwongStocks Sep. 10 at 1:04 PM
$CTOR CTOR files prospectus for $9M offering https://www.sec.gov/Archives/edgar/data/1851484/000121390025086384/ea0256104-424b5_citius.htm 5,142,858 Shares at $1.75, gross proceeds $9M. After fees and expenses, net proceeds expected to be $7.48M. The shares are registered pursuant to the $200M shelf filed earlier in September. CTOR's outstanding shares will be 83,513,442. Offering expected to close Sept 10. 65 day lock-up (approx Nov 14). 5,142,858 warrants will be issued in a concurrent private placement, with a $1.84 exercise price. The warrants will be registered under a separate S-1. Amendment to Promissory Note: In Aug 2024, CTOR issued a promissory note to $CTXR for $3.8M. Under the original terms, the Note had to be repaid if CTOR did a single capital raise of at least $10M. CTOR will now repay the $3.8M Note if CTOR does a series of raises that provides gross proceeds of at least $30 million. So far, CTOR raised $18M in gross proceeds. After they raise an additional $12M, they must repay CTXR. No updated cash runway in the filing.
0 · Reply
Noname2022
Noname2022 Sep. 10 at 2:14 AM
$CTXR $TLPH Still think Cormedix has more acquisitions ahead, would like to see a licensing deal for Mino Lok https://finance.yahoo.com/news/cormedix-announces-strategic-minority-investment-123000709.html https://cormedix.com/cormedix-completes-acquisition-of-melinta-therapeutics-raises-financial-guidance-and-announces-new-leadership-team/
2 · Reply
Applebat
Applebat Sep. 9 at 5:31 PM
$CTXR if you are buying this company, you hate monkey. Pure and simple
2 · Reply
SweStonk
SweStonk Sep. 9 at 3:32 PM
$CTXR $CTOR So they just diluted but still need to raise additional capital in the future to get enough to launch lymphir. We wont see lymphir launch this year. Q4 2026 if we gonna stay on track for Mazurs real timeline 😂
1 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Sep. 9 at 1:55 PM
$NNVC 🚀 Tiny float. Massive market. Real catalysts ahead. 🦠 Why it matters NNVC’s nanoviricide tech mimics human cells to trap & destroy viruses like Mpox, measles, flu, and COVID before they can spread. 📊 Technical Picture : Downtrend broken → momentum shift in play ⚡ Strong bounce off long-term support ✅ Volume surge shows buyers stepping in 🔥 💊 Pipeline & Catalysts : Lead drug NV-387 aimed at multi-billion-$ viral markets ⚠️ Phase II Mpox trial set for late 2025 → first human data expected 2026 🧪 Flu season around the corner → added spotlight 🍂 🎯 Levels to Watch $1.41 (Support) → $1.49 (Current price ) → $1.53 (1️⃣) → $1.57 (2️⃣) → $1.80 (3️⃣) → $1.92$ (4️⃣) 🚨 Antiviral innovation + technical momentum = a setup worth watching. #Advertisement #stocks #StocksInFocus #StockTrading #InvestingIdeas #MarketMovers #StockWatchlist #WallStreet #BreakoutStocks #StocksToBuy #MomentumTrading Peers : $CTXR $TNXP $BIVI $HGEN
0 · Reply
TwongStocks
TwongStocks Sep. 9 at 12:58 PM
Waiting for the prospectus for confirmation. After this offering, $CTOR should have 83,513,442 outstanding shares, assuming no warrant exercises. If that is correct, then $CTXR's ownership stake in CTOR will drop from 84.3% to 79.1% after this offering.
1 · Reply
Latest News on CTXR
Analysts Hunt for Undervalued Biotech Stocks

Jul 17, 2024, 8:00 AM EDT - 1 year ago

Analysts Hunt for Undervalued Biotech Stocks


Bloodstream Infections - From Threats to Solutions

Jul 11, 2024, 11:00 AM EDT - 1 year ago

Bloodstream Infections - From Threats to Solutions


TwongStocks
TwongStocks Sep. 12 at 8:27 PM
$CTXR files an amended 13D updating their ownership position in $CTOR. Ownership stake drops from 84.3% to 79.1% as a result of CTOR's offering. https://www.sec.gov/Archives/edgar/data/1506251/000121390025087227/xslSCHEDULE_13D_X01/primary_doc.xml CTXR still owns 66,049,615 shares (unchanged) CTOR now has 83,513,442 outstanding shares. CTXR owns 79.1%
0 · Reply
Applebat
Applebat Sep. 12 at 6:47 PM
$CTXR Lymphir gonna launch ANY DAY NOW! 🙄
0 · Reply
Idkwhattonamemyself
Idkwhattonamemyself Sep. 12 at 5:49 PM
$CTXR a securities fraud lawsuit likely won’t be possible because the lawsuit won’t make the lawyers any money.
1 · Reply
BALUGA825
BALUGA825 Sep. 11 at 2:49 PM
$CTOR $CTXR Lez Go ! Market is good today and probably tomorrow too. Slingshot for next week....
0 · Reply
TwongStocks
TwongStocks Sep. 10 at 1:04 PM
$CTOR CTOR files prospectus for $9M offering https://www.sec.gov/Archives/edgar/data/1851484/000121390025086384/ea0256104-424b5_citius.htm 5,142,858 Shares at $1.75, gross proceeds $9M. After fees and expenses, net proceeds expected to be $7.48M. The shares are registered pursuant to the $200M shelf filed earlier in September. CTOR's outstanding shares will be 83,513,442. Offering expected to close Sept 10. 65 day lock-up (approx Nov 14). 5,142,858 warrants will be issued in a concurrent private placement, with a $1.84 exercise price. The warrants will be registered under a separate S-1. Amendment to Promissory Note: In Aug 2024, CTOR issued a promissory note to $CTXR for $3.8M. Under the original terms, the Note had to be repaid if CTOR did a single capital raise of at least $10M. CTOR will now repay the $3.8M Note if CTOR does a series of raises that provides gross proceeds of at least $30 million. So far, CTOR raised $18M in gross proceeds. After they raise an additional $12M, they must repay CTXR. No updated cash runway in the filing.
0 · Reply
Noname2022
Noname2022 Sep. 10 at 2:14 AM
$CTXR $TLPH Still think Cormedix has more acquisitions ahead, would like to see a licensing deal for Mino Lok https://finance.yahoo.com/news/cormedix-announces-strategic-minority-investment-123000709.html https://cormedix.com/cormedix-completes-acquisition-of-melinta-therapeutics-raises-financial-guidance-and-announces-new-leadership-team/
2 · Reply
Applebat
Applebat Sep. 9 at 5:31 PM
$CTXR if you are buying this company, you hate monkey. Pure and simple
2 · Reply
SweStonk
SweStonk Sep. 9 at 3:32 PM
$CTXR $CTOR So they just diluted but still need to raise additional capital in the future to get enough to launch lymphir. We wont see lymphir launch this year. Q4 2026 if we gonna stay on track for Mazurs real timeline 😂
1 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Sep. 9 at 1:55 PM
$NNVC 🚀 Tiny float. Massive market. Real catalysts ahead. 🦠 Why it matters NNVC’s nanoviricide tech mimics human cells to trap & destroy viruses like Mpox, measles, flu, and COVID before they can spread. 📊 Technical Picture : Downtrend broken → momentum shift in play ⚡ Strong bounce off long-term support ✅ Volume surge shows buyers stepping in 🔥 💊 Pipeline & Catalysts : Lead drug NV-387 aimed at multi-billion-$ viral markets ⚠️ Phase II Mpox trial set for late 2025 → first human data expected 2026 🧪 Flu season around the corner → added spotlight 🍂 🎯 Levels to Watch $1.41 (Support) → $1.49 (Current price ) → $1.53 (1️⃣) → $1.57 (2️⃣) → $1.80 (3️⃣) → $1.92$ (4️⃣) 🚨 Antiviral innovation + technical momentum = a setup worth watching. #Advertisement #stocks #StocksInFocus #StockTrading #InvestingIdeas #MarketMovers #StockWatchlist #WallStreet #BreakoutStocks #StocksToBuy #MomentumTrading Peers : $CTXR $TNXP $BIVI $HGEN
0 · Reply
TwongStocks
TwongStocks Sep. 9 at 12:58 PM
Waiting for the prospectus for confirmation. After this offering, $CTOR should have 83,513,442 outstanding shares, assuming no warrant exercises. If that is correct, then $CTXR's ownership stake in CTOR will drop from 84.3% to 79.1% after this offering.
1 · Reply
Bronco6970
Bronco6970 Sep. 9 at 12:42 PM
$CTXR Mazur strikes again. Thief
0 · Reply
SweStonk
SweStonk Sep. 9 at 12:39 PM
$CTXR only 9m offering over @ CTOR. Means nothing goes back to CTXR. Dilution incoming any day here to keep CTXR running 😂
1 · Reply
TwongStocks
TwongStocks Sep. 9 at 12:32 PM
$CTOR $CTXR New offering for CTOR https://www.prnewswire.com/news-releases/citius-oncology-announces-pricing-of-9-0-million-registered-direct-offering-and-concurrent-private-placement-302550263.html 5,142,858 shares at $1.75 . 5,142,858 warrants at $1.84.
0 · Reply
DrKyle
DrKyle Sep. 8 at 6:24 PM
2 · Reply
irtaza5
irtaza5 Sep. 6 at 8:11 AM
2 · Reply
SweStonk
SweStonk Sep. 5 at 9:48 PM
$CTXR Lower lows, no money, upcoming dilution.
0 · Reply
Greyghost013
Greyghost013 Sep. 5 at 9:46 PM
$CTXR well once again It’s up as it has been all week and will continue into next week when I sell and make money. So all is well ……you do you and I’ll make money.
1 · Reply
SweStonk
SweStonk Sep. 5 at 9:42 PM
$CTXR apperently this guy thinks one green day take away the fact that this company is running on fumes and dilution will make SP go up 😂 Do we have another Lenny here? Dont he understand the fact that any dilution make SP plummet?
1 · Reply
Greyghost013
Greyghost013 Sep. 5 at 8:28 PM
$CTXR well apparently a lot of fools bought today. Close of 1.23. On the upswing into next week.
1 · Reply
BALUGA825
BALUGA825 Sep. 5 at 4:54 PM
$CTOR $CTXR I dont think they will go lower than the highlighted pps.is that the warrant price ?
1 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 5 at 4:31 PM
$CTXR Really good write-up that perfectly summarizes CTXR's present situation. So if you want to bring your CTXR knowledge up to date or just discover CTXR, this is required reading. https://beyondspx.com/quote/CTXR/citius-pharmaceuticals-lymphir-s-commercial-dawn-and-the-quest-for-sustainable-growth-nasdaq-ctxr#analysis
1 · Reply
SweStonk
SweStonk Sep. 5 at 3:54 PM
$CTXR No money, they need to dilute. Only a fool would buy no, knowing dilution will happen any day and OS will increase with what? 18m shares? At the moment we have like 17m OS this means we will see around the DOUBLE. What do you think will happen with SP when that happen? Your shares today will be worth half. R/S invetible
0 · Reply